Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Trojano

Showing results (111-120 of 342) with videos related to

Pageof 35
Sort By:
Journal of Neurology|February 20, 2021
Therapeutic recommendations and seasonal influenza vaccine for multiple sclerosis patients in treatment with ocrelizumab: an expert consensusMassimo Filippi, Ruggero Capra, Diego Centonze, et al.
Glia|February 21, 2009
Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodiesGrazia Paola Nicchia, Mauro Mastrototaro, Andrea Rossi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 8, 2006
The Italian Multiple Sclerosis Database Network (MSDN): the risk of worsening according to IFNbeta exposure in multiple sclerosisMaria Trojano, Pierluigi Russo, Aurora Fuiani, et al.
Journal of Neurology|January 23, 2014
The MoSt Project--more steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in ItalyRuggero Capra, Mario Alberto Battaglia, Antonio Gaudioso, et al.
Age and Ageing|March 23, 2011
Age-related changes of serum N-acetyl-aspartate in healthy controlsMaddalena Ruggieri, Carla Tortorella, Edmondo Ceci, et al.
Plos One|October 19, 2013
Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS studyFrancesco Patti, Vincenzo Brescia Morra, Maria Pia Amato, et al.
Brain and Behavior|January 19, 2019
Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot studyMaria Liguori, Nicoletta Nuzziello, Marta Simone, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 29, 2011
Longitudinal changes in social functioning in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II)Francesco Patti, Maria Pia Amato, Maria Trojano, et al.
Neurobiology of Disease|June 18, 2011
Cerebral cortex demyelination and oligodendrocyte precursor response to experimental autoimmune encephalomyelitisFrancesco Girolamo, Giovanni Ferrara, Maurizio Strippoli, et al.
BMC Neurology|October 18, 2011
Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) studyStefano Bastianello, Elisabetta Giugni, Maria Pia Amato, et al.
Pageof 35

Showing results (111-120 of 342) with videos related to

Sort By:
Pageof 35
Journal of Neurology|February 20, 2021
Therapeutic recommendations and seasonal influenza vaccine for multiple sclerosis patients in treatment with ocrelizumab: an expert consensusMassimo Filippi, Ruggero Capra, Diego Centonze, et al.
Glia|February 21, 2009
Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodiesGrazia Paola Nicchia, Mauro Mastrototaro, Andrea Rossi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 8, 2006
The Italian Multiple Sclerosis Database Network (MSDN): the risk of worsening according to IFNbeta exposure in multiple sclerosisMaria Trojano, Pierluigi Russo, Aurora Fuiani, et al.
Journal of Neurology|January 23, 2014
The MoSt Project--more steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in ItalyRuggero Capra, Mario Alberto Battaglia, Antonio Gaudioso, et al.
Age and Ageing|March 23, 2011
Age-related changes of serum N-acetyl-aspartate in healthy controlsMaddalena Ruggieri, Carla Tortorella, Edmondo Ceci, et al.
Plos One|October 19, 2013
Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS studyFrancesco Patti, Vincenzo Brescia Morra, Maria Pia Amato, et al.
Brain and Behavior|January 19, 2019
Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot studyMaria Liguori, Nicoletta Nuzziello, Marta Simone, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 29, 2011
Longitudinal changes in social functioning in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II)Francesco Patti, Maria Pia Amato, Maria Trojano, et al.
Neurobiology of Disease|June 18, 2011
Cerebral cortex demyelination and oligodendrocyte precursor response to experimental autoimmune encephalomyelitisFrancesco Girolamo, Giovanni Ferrara, Maurizio Strippoli, et al.
BMC Neurology|October 18, 2011
Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) studyStefano Bastianello, Elisabetta Giugni, Maria Pia Amato, et al.
Pageof 35